Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
11/2014
11/11/2014US8883967 Branched amphipathic oligo-peptides that self-assemble into vesicles
11/11/2014US8883966 RAB6KIFL/KIF20A epitope peptide and vaccines containing the same
11/11/2014US8883965 Compounds
11/11/2014US8883962 Zinc-responsive peptides, and methods of use thereof
11/11/2014US8883742 Peptide increasing fusiogenic capacity of a gamete
11/11/2014US8883740 Peptides, compositions, and uses thereof
11/11/2014US8883734 Proteasome-activating anti-aging peptides and compositions containing same
11/11/2014US8883721 Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
11/11/2014US8883720 Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity
11/11/2014US8883718 Treating cancer
11/11/2014US8883480 Antiviral peptide against avian influenza virus H9N2
11/11/2014US8883450 Signal peptide, and use thereof for producing recombinant proteins
11/11/2014US8883413 Compstatin analogs with improved activity
11/11/2014US8883173 Synthetic antigenic peptides and lipopeptides derived from Mycobacterium avium subsp. paratuberculosis
11/11/2014US8883153 Methods for preventing and treating angioedema
11/06/2014US20140329989 Preparation of micafungin intermediates
11/06/2014US20140329765 Methods and Compositions for the Treatment of Gastrointestinal Disorders
11/06/2014US20140329760 Peptides and nanoparticles for therapeutic and diagnostic applications
11/06/2014US20140329758 Peptide inhibitors for mediating stress responses
11/06/2014US20140329753 Angiogenic active lytic peptides
11/06/2014US20140329743 Method of Treating Melanocortin-4 Receptor-Associated Disorders in Heterozygous Carriers
11/06/2014US20140329739 Antibiotic peptide and preparation method therefor and application therefor
11/06/2014US20140329738 Agonists of Guanylate Cyclase Useful For the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
11/06/2014US20140329737 Development of Novel Macromolecule Transduction Domain with Improved Cell Permeability and Method for Using Same
11/06/2014US20140328831 Single domain tdf-related compounds and analogs thereof
11/06/2014US20140328782 Peptide inhibiting matrix metalloproteanases activity and use thereof
11/04/2014US8877890 Melanocortin-1 receptor-specific cyclic peptides
11/04/2014US8877889 Tumor cell-killing peptides
11/04/2014US8877777 Process for purifying cyclolipopeptide compounds or the salts thereof
11/04/2014US8877738 Antipathogenic peptides
11/04/2014US8877716 Peptide derivatives, preparation and uses thereof
11/04/2014US8877715 Cytotoxic conjugates having neuropeptide Y receptor binding compound
11/04/2014US8877713 Anti-aging peptides and cosmetic and/or pharmaceutical composition containing same
11/04/2014US8877252 Polymer-based sustained release device
11/04/2014US8877203 Composition and method for preventing and treating immune-related disorder
11/04/2014US8877161 GM1-like peptides and uses thereof
10/2014
10/30/2014US20140323689 Process for the preparation of a viral protease inhibitor and intermediates thereof
10/30/2014US20140323414 Inotropic compounds
10/30/2014US20140323407 Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
10/30/2014US20140323397 Treatments for gastrointestinal disorders
10/30/2014US20140323393 Uses Of Peptides to Treat Brain Injury and Disease
10/30/2014US20140323392 Methods and compositions related to inhibition of viral entry
10/30/2014US20140322790 Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria
10/30/2014US20140322335 Suspensions of cyclosporin a form 2
10/30/2014US20140322332 Antagonists of muc1
10/30/2014US20140322307 Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions
10/30/2014US20140322306 Medical Use
10/30/2014US20140322302 Therapeutic peptides
10/30/2014US20140322279 Self-Assembling Peptides Incorporating Modifications and Methods of Use Thereof
10/30/2014US20140322253 Cyclin a1-targeted t-cell immunotherapy for cancer
10/30/2014US20140322252 Peptides for Treating Alzheimers's Disease and Related Conditions
10/30/2014US20140322251 Peptides for Progressive Treating Multi-Focal Leukoencephalopathy and Related Conditions
10/30/2014US20140322250 Peptides for the Treatment of Multiple Sclerosis and Related Diseases
10/30/2014US20140322227 Peptides for treatment of bone deficiency and autoimmune disorders
10/30/2014US20140322205 Rtef-1 variants and the use thereof for inhibition of angiogenesis
10/30/2014US20140322132 Fragments of p97 and uses thereof
10/28/2014US8871904 Processes and intermediates
10/28/2014US8871902 Immunogenic POTE peptides and methods of use
10/28/2014US8871901 Phage constructs, sequences and antigenic compositions for immunocontraception of animals
10/28/2014US8871899 Control of viral-host membrane fusion with hydrogen bond surrogate-based artificial helices
10/28/2014US8871725 Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs
10/28/2014US8871720 Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus
10/28/2014US8871718 Transglutaminase inhibitors and methods of use thereof
10/28/2014US8871708 Compositions and methods for treating AIDS or cancer by inhibiting the secretion of microparticles
10/23/2014US20140316107 Cyclin based inhibitors of cdk2 and cdk4
10/23/2014US20140316106 Integrin-blocking polypeptides and uses thereof
10/23/2014US20140316104 Cyclosporin derivatives
10/23/2014US20140315831 Synthesis of Libraries of Peptide Tertiary Amides
10/23/2014US20140315827 Crystalline form of cyclosporine a, methods of preparation, and methods for use thereof
10/23/2014US20140315824 Peptide preparations and peptides with antitumour activity
10/23/2014US20140315823 Peptide compounds for suppressing inflammation
10/23/2014US20140315818 Methods and products for treating preeclampsia and modulating blood pressure
10/23/2014US20140315799 Compositions and Methods for Regulating Glucose Metabolism
10/23/2014US20140315784 Binding Inhibitors of the Beta. Transducin Repeat-Containing Protein
10/23/2014US20140315253 Activated collagen scaffold materials and their special fused active restoration factors
10/23/2014US20140314858 Ipnv-isav bivalent vaccine using a virus-like particle-based platform and methods of using the same
10/23/2014US20140314823 Antimicrobial peptides
10/23/2014US20140314800 Beta-lactoglobulin peptides for treating cow's milk protein allergy
10/21/2014US8865871 Antibodies and kits for immunodetection of epitope tags
10/21/2014US8865658 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
10/21/2014US8865656 Beta-hairpin peptidomimetics having CXCR4 antagonizing activity
10/21/2014US8865655 Depsipeptides and their therapeutic use
10/21/2014US8865648 Monomeric and dimeric forms of adiponectin receptor fragments and methods of use
10/21/2014US8865347 Digital alloys and methods for forming the same
10/21/2014US8865125 Radioiodination method
10/16/2014US20140309401 Dpp-4 inhibitor
10/16/2014US20140309174 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/16/2014US20140309170 Anti-angiogenic peptides and uses thereof
10/16/2014US20140309162 Novel antibacterial and fungicidal peptide in which lysine and tryptophan residues are repeated, and use thereof
10/16/2014US20140309157 Wnt family-derived peptides and use thereof
10/16/2014US20140309126 Peptide binding to graphitic materials and phage including same
10/16/2014US20140308318 Inhibitors against Endosomal/Lysosomal Enzymes
10/16/2014US20140308306 Compositions and methods for treatment of kidney diseases
10/16/2014US20140308289 Extracellular histones as biomarkers for prognosis and molecular targets for therapy
10/16/2014US20140308261 HLA-DR7 HY epitope and method for treating leukaemia
10/14/2014US8859734 Method for the selective enrichment and labeling of phosphorproteins
10/14/2014US8859733 Compositions and methods for promoting wound healing and tissue regeneration
10/14/2014US8859730 Native chemical ligation at serine and threonine sites
10/14/2014US8859729 Growth hormone releasing peptides
10/14/2014US8859727 Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 423